ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Intelligence Drug Development Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-37U11211
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Artificial Intelligence Drug Development Market Research Report 2022
BUY CHAPTERS

Global Artificial Intelligence Drug Development Market Research Report 2024

Code: QYRE-Auto-37U11211
Report
April 2024
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
InSilico Medicine
Cyclica Inc
XtalPi
Exscientia Ltd
AiCure
Atomwise
Biovista Inc
Breg
Numerate Inc
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics

Artificial Intelligence Drug Development Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Artificial Intelligence Drug Development Market

Artificial Intelligence Drug Development Market

The global Artificial Intelligence Drug Development market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Drug Development.

Report Scope

The Artificial Intelligence Drug Development market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence Drug Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence Drug Development companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Artificial Intelligence Drug Development Market Report

Report Metric Details
Report Name Artificial Intelligence Drug Development Market
CAGR 5%
Segment by Type
  • Drug Design
  • Drug Synthesis
  • Other
Segment by Application
  • Tumor
  • Nervous System
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg，Inc., Numerate, Cloud Pharmaceuticals, IBM, NuMedii, BenevolentAI, Lam Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Artificial Intelligence Drug Development companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Artificial Intelligence Drug Development Market report?

Ans: The main players in the Artificial Intelligence Drug Development Market are Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg，Inc., Numerate, Cloud Pharmaceuticals, IBM, NuMedii, BenevolentAI, Lam Therapeutics

What are the Application segmentation covered in the Artificial Intelligence Drug Development Market report?

Ans: The Applications covered in the Artificial Intelligence Drug Development Market report are Tumor, Nervous System, Other

What are the Type segmentation covered in the Artificial Intelligence Drug Development Market report?

Ans: The Types covered in the Artificial Intelligence Drug Development Market report are Drug Design, Drug Synthesis, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Drug Development Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug Design
1.2.3 Drug Synthesis
1.2.4 Other
1.3 Market by Application
1.3.1 Global Artificial Intelligence Drug Development Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Tumor
1.3.3 Nervous System
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Drug Development Market Perspective (2019-2030)
2.2 Artificial Intelligence Drug Development Growth Trends by Region
2.2.1 Global Artificial Intelligence Drug Development Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence Drug Development Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence Drug Development Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence Drug Development Market Dynamics
2.3.1 Artificial Intelligence Drug Development Industry Trends
2.3.2 Artificial Intelligence Drug Development Market Drivers
2.3.3 Artificial Intelligence Drug Development Market Challenges
2.3.4 Artificial Intelligence Drug Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Drug Development Players by Revenue
3.1.1 Global Top Artificial Intelligence Drug Development Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence Drug Development Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence Drug Development Revenue
3.4 Global Artificial Intelligence Drug Development Market Concentration Ratio
3.4.1 Global Artificial Intelligence Drug Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug Development Revenue in 2023
3.5 Artificial Intelligence Drug Development Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence Drug Development Product Solution and Service
3.7 Date of Enter into Artificial Intelligence Drug Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Drug Development Breakdown Data by Type
4.1 Global Artificial Intelligence Drug Development Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence Drug Development Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence Drug Development Breakdown Data by Application
5.1 Global Artificial Intelligence Drug Development Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence Drug Development Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence Drug Development Market Size (2019-2030)
6.2 North America Artificial Intelligence Drug Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence Drug Development Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence Drug Development Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence Drug Development Market Size (2019-2030)
7.2 Europe Artificial Intelligence Drug Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence Drug Development Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence Drug Development Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Drug Development Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence Drug Development Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence Drug Development Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence Drug Development Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence Drug Development Market Size (2019-2030)
9.2 Latin America Artificial Intelligence Drug Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence Drug Development Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence Drug Development Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Drug Development Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence Drug Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence Drug Development Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence Drug Development Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Detail
11.1.2 Insilico Medicine Business Overview
11.1.3 Insilico Medicine Artificial Intelligence Drug Development Introduction
11.1.4 Insilico Medicine Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.1.5 Insilico Medicine Recent Development
11.2 Cyclica
11.2.1 Cyclica Company Detail
11.2.2 Cyclica Business Overview
11.2.3 Cyclica Artificial Intelligence Drug Development Introduction
11.2.4 Cyclica Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.2.5 Cyclica Recent Development
11.3 XtalPi Inc.
11.3.1 XtalPi Inc. Company Detail
11.3.2 XtalPi Inc. Business Overview
11.3.3 XtalPi Inc. Artificial Intelligence Drug Development Introduction
11.3.4 XtalPi Inc. Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.3.5 XtalPi Inc. Recent Development
11.4 Exscientia Limited
11.4.1 Exscientia Limited Company Detail
11.4.2 Exscientia Limited Business Overview
11.4.3 Exscientia Limited Artificial Intelligence Drug Development Introduction
11.4.4 Exscientia Limited Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.4.5 Exscientia Limited Recent Development
11.5 AiCure, LLC
11.5.1 AiCure, LLC Company Detail
11.5.2 AiCure, LLC Business Overview
11.5.3 AiCure, LLC Artificial Intelligence Drug Development Introduction
11.5.4 AiCure, LLC Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.5.5 AiCure, LLC Recent Development
11.6 Atomwise
11.6.1 Atomwise Company Detail
11.6.2 Atomwise Business Overview
11.6.3 Atomwise Artificial Intelligence Drug Development Introduction
11.6.4 Atomwise Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.6.5 Atomwise Recent Development
11.7 Biovista Inc.
11.7.1 Biovista Inc. Company Detail
11.7.2 Biovista Inc. Business Overview
11.7.3 Biovista Inc. Artificial Intelligence Drug Development Introduction
11.7.4 Biovista Inc. Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.7.5 Biovista Inc. Recent Development
11.8 Breg，Inc.
11.8.1 Breg，Inc. Company Detail
11.8.2 Breg，Inc. Business Overview
11.8.3 Breg，Inc. Artificial Intelligence Drug Development Introduction
11.8.4 Breg，Inc. Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.8.5 Breg，Inc. Recent Development
11.9 Numerate
11.9.1 Numerate Company Detail
11.9.2 Numerate Business Overview
11.9.3 Numerate Artificial Intelligence Drug Development Introduction
11.9.4 Numerate Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.9.5 Numerate Recent Development
11.10 Cloud Pharmaceuticals
11.10.1 Cloud Pharmaceuticals Company Detail
11.10.2 Cloud Pharmaceuticals Business Overview
11.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Introduction
11.10.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.10.5 Cloud Pharmaceuticals Recent Development
11.11 IBM
11.11.1 IBM Company Detail
11.11.2 IBM Business Overview
11.11.3 IBM Artificial Intelligence Drug Development Introduction
11.11.4 IBM Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.11.5 IBM Recent Development
11.12 NuMedii
11.12.1 NuMedii Company Detail
11.12.2 NuMedii Business Overview
11.12.3 NuMedii Artificial Intelligence Drug Development Introduction
11.12.4 NuMedii Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.12.5 NuMedii Recent Development
11.13 BenevolentAI
11.13.1 BenevolentAI Company Detail
11.13.2 BenevolentAI Business Overview
11.13.3 BenevolentAI Artificial Intelligence Drug Development Introduction
11.13.4 BenevolentAI Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.13.5 BenevolentAI Recent Development
11.14 Lam Therapeutics
11.14.1 Lam Therapeutics Company Detail
11.14.2 Lam Therapeutics Business Overview
11.14.3 Lam Therapeutics Artificial Intelligence Drug Development Introduction
11.14.4 Lam Therapeutics Revenue in Artificial Intelligence Drug Development Business (2019-2024)
11.14.5 Lam Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
InSilico Medicine
Cyclica Inc
XtalPi
Exscientia Ltd
AiCure
Atomwise
Biovista Inc
Breg
Numerate Inc
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics
List of Tables
    Table 1. Global Artificial Intelligence Drug Development Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Drug Design
    Table 3. Key Players of Drug Synthesis
    Table 4. Key Players of Other
    Table 5. Global Artificial Intelligence Drug Development Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Artificial Intelligence Drug Development Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Artificial Intelligence Drug Development Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Artificial Intelligence Drug Development Market Share by Region (2019-2024)
    Table 9. Global Artificial Intelligence Drug Development Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Artificial Intelligence Drug Development Market Share by Region (2025-2030)
    Table 11. Artificial Intelligence Drug Development Market Trends
    Table 12. Artificial Intelligence Drug Development Market Drivers
    Table 13. Artificial Intelligence Drug Development Market Challenges
    Table 14. Artificial Intelligence Drug Development Market Restraints
    Table 15. Global Artificial Intelligence Drug Development Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Artificial Intelligence Drug Development Market Share by Players (2019-2024)
    Table 17. Global Top Artificial Intelligence Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug Development as of 2023)
    Table 18. Ranking of Global Top Artificial Intelligence Drug Development Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Artificial Intelligence Drug Development Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Artificial Intelligence Drug Development Product Solution and Service
    Table 22. Date of Enter into Artificial Intelligence Drug Development Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Artificial Intelligence Drug Development Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Artificial Intelligence Drug Development Revenue Market Share by Type (2019-2024)
    Table 26. Global Artificial Intelligence Drug Development Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Artificial Intelligence Drug Development Revenue Market Share by Type (2025-2030)
    Table 28. Global Artificial Intelligence Drug Development Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Artificial Intelligence Drug Development Revenue Market Share by Application (2019-2024)
    Table 30. Global Artificial Intelligence Drug Development Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Artificial Intelligence Drug Development Revenue Market Share by Application (2025-2030)
    Table 32. North America Artificial Intelligence Drug Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Artificial Intelligence Drug Development Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Artificial Intelligence Drug Development Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Artificial Intelligence Drug Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Artificial Intelligence Drug Development Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Artificial Intelligence Drug Development Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Artificial Intelligence Drug Development Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Artificial Intelligence Drug Development Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Artificial Intelligence Drug Development Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Artificial Intelligence Drug Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Artificial Intelligence Drug Development Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Artificial Intelligence Drug Development Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Artificial Intelligence Drug Development Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Artificial Intelligence Drug Development Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Artificial Intelligence Drug Development Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Insilico Medicine Company Detail
    Table 48. Insilico Medicine Business Overview
    Table 49. Insilico Medicine Artificial Intelligence Drug Development Product
    Table 50. Insilico Medicine Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 51. Insilico Medicine Recent Development
    Table 52. Cyclica Company Detail
    Table 53. Cyclica Business Overview
    Table 54. Cyclica Artificial Intelligence Drug Development Product
    Table 55. Cyclica Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 56. Cyclica Recent Development
    Table 57. XtalPi Inc. Company Detail
    Table 58. XtalPi Inc. Business Overview
    Table 59. XtalPi Inc. Artificial Intelligence Drug Development Product
    Table 60. XtalPi Inc. Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 61. XtalPi Inc. Recent Development
    Table 62. Exscientia Limited Company Detail
    Table 63. Exscientia Limited Business Overview
    Table 64. Exscientia Limited Artificial Intelligence Drug Development Product
    Table 65. Exscientia Limited Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 66. Exscientia Limited Recent Development
    Table 67. AiCure, LLC Company Detail
    Table 68. AiCure, LLC Business Overview
    Table 69. AiCure, LLC Artificial Intelligence Drug Development Product
    Table 70. AiCure, LLC Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 71. AiCure, LLC Recent Development
    Table 72. Atomwise Company Detail
    Table 73. Atomwise Business Overview
    Table 74. Atomwise Artificial Intelligence Drug Development Product
    Table 75. Atomwise Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 76. Atomwise Recent Development
    Table 77. Biovista Inc. Company Detail
    Table 78. Biovista Inc. Business Overview
    Table 79. Biovista Inc. Artificial Intelligence Drug Development Product
    Table 80. Biovista Inc. Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 81. Biovista Inc. Recent Development
    Table 82. Breg，Inc. Company Detail
    Table 83. Breg，Inc. Business Overview
    Table 84. Breg，Inc. Artificial Intelligence Drug Development Product
    Table 85. Breg，Inc. Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 86. Breg，Inc. Recent Development
    Table 87. Numerate Company Detail
    Table 88. Numerate Business Overview
    Table 89. Numerate Artificial Intelligence Drug Development Product
    Table 90. Numerate Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 91. Numerate Recent Development
    Table 92. Cloud Pharmaceuticals Company Detail
    Table 93. Cloud Pharmaceuticals Business Overview
    Table 94. Cloud Pharmaceuticals Artificial Intelligence Drug Development Product
    Table 95. Cloud Pharmaceuticals Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 96. Cloud Pharmaceuticals Recent Development
    Table 97. IBM Company Detail
    Table 98. IBM Business Overview
    Table 99. IBM Artificial Intelligence Drug Development Product
    Table 100. IBM Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 101. IBM Recent Development
    Table 102. NuMedii Company Detail
    Table 103. NuMedii Business Overview
    Table 104. NuMedii Artificial Intelligence Drug Development Product
    Table 105. NuMedii Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 106. NuMedii Recent Development
    Table 107. BenevolentAI Company Detail
    Table 108. BenevolentAI Business Overview
    Table 109. BenevolentAI Artificial Intelligence Drug Development Product
    Table 110. BenevolentAI Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 111. BenevolentAI Recent Development
    Table 112. Lam Therapeutics Company Detail
    Table 113. Lam Therapeutics Business Overview
    Table 114. Lam Therapeutics Artificial Intelligence Drug Development Product
    Table 115. Lam Therapeutics Revenue in Artificial Intelligence Drug Development Business (2019-2024) & (US$ Million)
    Table 116. Lam Therapeutics Recent Development
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Artificial Intelligence Drug Development Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Artificial Intelligence Drug Development Market Share by Type: 2023 VS 2030
    Figure 3. Drug Design Features
    Figure 4. Drug Synthesis Features
    Figure 5. Other Features
    Figure 6. Global Artificial Intelligence Drug Development Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Artificial Intelligence Drug Development Market Share by Application: 2023 VS 2030
    Figure 8. Tumor Case Studies
    Figure 9. Nervous System Case Studies
    Figure 10. Other Case Studies
    Figure 11. Artificial Intelligence Drug Development Report Years Considered
    Figure 12. Global Artificial Intelligence Drug Development Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Artificial Intelligence Drug Development Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Artificial Intelligence Drug Development Market Share by Region: 2023 VS 2030
    Figure 15. Global Artificial Intelligence Drug Development Market Share by Players in 2023
    Figure 16. Global Top Artificial Intelligence Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug Development as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Artificial Intelligence Drug Development Revenue in 2023
    Figure 18. North America Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Artificial Intelligence Drug Development Market Share by Country (2019-2030)
    Figure 20. United States Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Artificial Intelligence Drug Development Market Share by Country (2019-2030)
    Figure 24. Germany Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Artificial Intelligence Drug Development Market Share by Region (2019-2030)
    Figure 32. China Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Artificial Intelligence Drug Development Market Share by Country (2019-2030)
    Figure 40. Mexico Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Artificial Intelligence Drug Development Market Share by Country (2019-2030)
    Figure 44. Turkey Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Artificial Intelligence Drug Development Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Insilico Medicine Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 47. Cyclica Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 48. XtalPi Inc. Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 49. Exscientia Limited Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 50. AiCure, LLC Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 51. Atomwise Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 52. Biovista Inc. Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 53. Breg，Inc. Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 54. Numerate Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 55. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 56. IBM Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 57. NuMedii Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 58. BenevolentAI Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 59. Lam Therapeutics Revenue Growth Rate in Artificial Intelligence Drug Development Business (2019-2024)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Artificial Intelligence For Drug Development and Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence AI in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI Pharma Market Research Report 2025
Global Artificial Intelligence In Diagnostic Market Research Report 2024
AI in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence in IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence AI in Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI Image assisted Diagnosis Software Market Research Report 2025
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024
Global AI Imaging and Diagnostics Software Market Research Report 2025
Global Artificial Intelligence Pathology Diagnosis Market Research Report 2024
Global AI Imaging and Diagnostics System Market Research Report 2025
Global AI Robot in Heart Treatment Market Research Report 2025
AI enabled Diagnostic Imaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medicine Compounding Robot Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI for Early Cancer Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Developing Platforms by Artificial Intelligence AI Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions